• Lianlian DigiTech HK$657 million IPO
• Laekna HK$791 million Hong Kong IPO
• Interra Acquisition Corporation’s HK$1 billion Hong Kong IPO
• Biocytogen’s HK$549 million Hong Kong IPO
• Duddell Street Acquisition Corporation’s $1.1 billion de-SPAC
• Meican Group’s $100 million Series E financing
• Zai Lab’s $857.5 million offering of ADSs and ordinary shares
• New Horizon Health’s $263 million Hong Kong IPO
• UP Fintech $183.1 million offering of American depositary shares

Haiyang’s representations before joining Davis Polk include the following:

Capital Markets and Other Corporate Finance

• ECMOHO’s $43.75 million U.S. IPO
• Hepalink’s $523 million Hong Kong IPO
• Kangji Medical’s $404 million Hong Kong IPO
• Mulsanne Group’s $112.6 million Hong Kong IPO
• AK Medical’s $64.4 million Hong Kong IPO
• Foxconn Group’s spin-off and listing of its subsidiary Foxconn Interconnect Technology on the Hong Kong Stock Exchange
• Universal Medical’s $514 million Hong Kong IPO
• Fuyao Glass’ $1.1 billion Hong Kong IPO
• Ozner Water’s $168 million Hong Kong IPO
• Nirvana Asia’s $261 million Hong Kong IPO
• A major Chinese home appliance retailer’s $250 million syndicate loan financing

Mergers & Acquisitions

• Foxconn Interconnect Technology’s $54.2 million purchase of certain preferred shares in Kantatsu from Sharp Corporation
• WuXi PharmaTech’s $3.3 billion going private transaction
• Shanda Games’ $1.9 billion going private transaction
• BGP, Inc.’s investment in and a joint venture with ION Geophysical
• A US listed company’s joint venture with a Chinese SOE affiliate

Compliance

• China Telecom
• Air China